Bio-Techne, Leica launch RNA probes for COVID-19 research

By The Science Advisory Board staff writers

August 19, 2020 -- Bio-Techne and Leica Biosystems have announced the automation of RNAscope COVID-19 probes on Bond Rx, Leica's staining platform, for research use only. This gives researchers the ability to automate COVID-19 research protocols, reduce labor, and speed up turnaround times.

Bio-Techne believes that the RNA probes will help researchers gain a greater understanding of the pathogenesis of COVID-19.

Leica's Bond Rx is a flexible, open staining platform that can run RNAscope (in duplex or multiplex) protocols. RNAscope probes are designed to detect SARS-CoV-2 viral RNA, SARS-CoV-2 viral replication sequences, and cellular receptors targeted by the virus such as angiotensin-converting enzyme 2 (ACE2) and transmembrane protease, serine 2 (TMPRSS2).

Bio-Techne releases new SARS recombinant antibody
Bio-Techne has launched a SARS-CoV-1/2 spike receptor-binding domain LlamaBody recombinant antibody that blocks the virus from binding to the host receptor,...
Bio-Techne, Kantaro launch COVID-19 serology test
Bio-Techne and Kantaro Biosciences have launched COVID-SeroIndex, a quantitative SARS-CoV-2 immunoglobulin G antibody research-use only kit.
Bio-Techne releases product for manufacturing
Bio-Techne has released GMP ProDots Proteins to support cell and gene therapy manufacturing workflows. The product will allow manufacturers to safely...
Bio-Techne releases new T-cell activation kit
Bio-Techne has released a new kit for cell and gene therapy manufacturing called GMP Cloudz Human T Cell Activation.

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter